文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

急诊科气管插管后镇静相关因素:来自国家急诊气道登记处的报告

Factors associated with post-intubation sedation after emergency department intubation: A Report from The National Emergency Airway Registry.
PubMed 文献 · Am J Emerg Med · 2019-05-06
一句话结论NEAR 登记显示急诊插管后 15 分钟内镇静率 77.5%,插管前/后低血压与镇静几率降低相关,快速序贯诱导与琥珀胆碱使用与镇静几率升高相关。

该研究对 2016 年 1 月 1 日至 2017 年 12 月 31 日期间来自 25 个急诊科的前瞻性收集数据库(国家急诊气道登记处 NEAR)进行回顾性分析,评估急诊气管插管后镇静的频率及相关因素。共纳入 11,748 例合格插管,其中 9,099 例(77.5%)在插管完成后 15 分钟内接受了插管后镇静,2,649 例(22.5%)未接受。插管前低血压(OR 0.27;95%CI 0.24-0.31)和插管后低血压(OR 0.27;95%CI 0.24-0.31)与插管后镇静几率降低相关;内科指征较创伤指征插管者镇静几率更高(OR 1.16;95%CI 1.05-1.28),快速序贯诱导者镇静几率更高(OR 15.15;95%CI 13.56-16.93),使用琥珀胆碱较长效神经肌肉阻滞剂(罗库溴铵或维库溴铵)者镇静几率更高(OR 1.89;95%CI 1.68-2.12)。作者结论认为 NEAR 中插管后镇静率高于既往报告,插管指征和琥珀胆碱使用等多种因素与接受插管后镇静的较高几率相关。

要点

  • 在 11,748 例急诊气管插管中,9,099 例(77.5%)在插管完成后 15 分钟内接受了插管后镇静,2,649 例(22.5%)未接受。
  • 插管前低血压与插管后镇静几率降低相关(OR 0.27;95%CI 0.24-0.31),插管后低血压同样与镇静几率降低相关(OR 0.27;95%CI 0.24-0.31)。
  • 内科指征插管较创伤指征插管者接受插管后镇静的几率更高(OR 1.16;95%CI 1.05-1.28)。
  • 快速序贯诱导者接受插管后镇静的几率更高(OR 15.15;95%CI 13.56-16.93)。
  • 使用琥珀胆碱较长效神经肌肉阻滞剂(罗库溴铵或维库溴铵)者接受插管后镇静的几率更高(OR 1.89;95%CI 1.68-2.12)。

适用人群与场景

  • 2016 年 1 月 1 日至 2017 年 12 月 31 日期间在 25 个急诊科接受气管插管的患者,共 11,748 例合格插管。

诊断标准与关键阈值

  • 插管后镇静定义为气管插管完成后 15 分钟内接受以下任一药物:丙泊酚、咪达唑仑、地西泮、氯胺酮、依托咪酯、芬太尼、吗啡。

研究设计与关键结果

  • 研究类型为对前瞻性收集数据库(NEAR,25 个急诊科,2016 年 1 月 1 日至 2017 年 12 月 31 日)的回顾性分析。
  • 11,748 例合格插管中 9,099 例(77.5%)接受插管后镇静,2,649 例(22.5%)未接受。
  • 插管前低血压与插管后镇静几率降低相关(OR 0.27;95%CI 0.24-0.31),插管后低血压同样与镇静几率降低相关(OR 0.27;95%CI 0.24-0.31)。
  • 内科指征较创伤指征插管者接受插管后镇静的几率更高(OR 1.16;95%CI 1.05-1.28)。
  • 快速序贯诱导者接受插管后镇静的几率更高(OR 15.15;95%CI 13.56-16.93)。
  • 使用琥珀胆碱较长效神经肌肉阻滞剂(罗库溴铵或维库溴铵)者接受插管后镇静的几率更高(OR 1.89;95%CI 1.68-2.12)。

证据类型、等级与局限

  • 证据类型:对前瞻性收集数据库(NEAR)的回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 研究提示急诊插管后镇静率高于既往报告,插管前或插管后低血压与接受插管后镇静的几率降低相关,内科指征、快速序贯诱导及使用琥珀胆碱与接受插管后镇静的几率升高相关。

指南或共识出处

  • 国家急诊气道登记处(National Emergency Airway Registry,NEAR)

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Previous work has suggested low rates of post-intubation sedation in patients undergoing endotracheal intubation (ETI) in the emergency department (ED) with limited data examining factors associated with sedation use. Utilizing a national database; we sought to determine the frequency of post-intubation sedation and associated factors.

METHODS: We performed a retrospective analysis of a prospectively collected database (National Emergency Airway Registry (NEAR) from 25 EDs from January 1, 2016 to December 31, 2017). Patients were considered to have received post-intubation sedation if they received any of the following medications within 15 min of ETI completion; propofol, midazolam, diazepam, ketamine, etomidate, fentanyl, and morphine. We calculated odds ratios for post-intubation sedation.

RESULTS: Of the 11,748 eligible intubations, 9099 received post-intubation sedation (77.5%) while 2649 did not (22.5%). Pre-intubation hypotension (odds ratio; 95% confidence Interval) (0.27; 0.24-0.31) and post-intubation hypotension (0.27; 0.24-0.31) were associated with lower odds of post-intubation sedation. Patients with a medical indication compared to a traumatic indication for ETI had higher odds of receiving post-intubation sedation (1.16; 1.05-1.28) as did those that underwent rapid sequence intubation (15.15; 13.56-16.93). Use of succinylcholine was associated with a higher odd of post-intubation sedation compared to a long-acting neuromuscular blocking agent (i.e. rocuronium or vecuronium) (1.89; 1.68-2.12).

CONCLUSION: Post-intubation sedation rates in NEAR are higher than previously reported and multiple factors including the indication for intubation and succinylcholine use, are associated with higher odds of receiving post-intubation sedation.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Lembersky O, Golz D, Kramer C, et al. Factors associated with post-intubation sedation after emergency department intubation: A Report from The National Emergency Airway Registry. Am J Emerg Med. 2019. PMID: 31130369. doi:10.1016/j.ajem.2019.05.010

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。